Salix to be Discussed on BloodHorse.com’s Talkin’ Horses
The Blood-Horse Staff
June 25, 2012
The medication furosemide (Salix) will be discussed by J. David Richardson, MD, and Foster Northrop, DVM.
The medication furosemide (Salix) will be discussed by J. David Richardson, MD, and Foster Northrop, DVM.
The TRA has endorsed a policy for equine medication reform supported by many industry stakeholders.
Dutch scientists determined that all non-natural head and neck positions affect horses’ breathing.
The International Federation of Horseracing Authorities and the Hong Konj Jockey club support the decision.
Kentucky horsemen, after the vote, said they intend to lobby lawmakers to oppose the regulation.
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
The measure would ban the use of furosemide on race-day in graded and listed stakes over a three-year period.
The drug, possibly being misused for its anabolic steroid properties, will be severely restricted next year.
The Salix debate will continue in early June when the KHRC holds a town hall meeting on the topic.
The KHRC will discuss a possible three-year phase-out of race-day furosemide in graded and listed stakes.
Salix is a medication used to prevent exercise-induced pulmonary hemorrhaging, also known as bleeding.
The witnesses all told Congress they don’t believe race-day medication has a place in Thoroughbred racing.
Study of horses with allergies showed a partial remission of allergy signs with nanoparticle administration
Researchers recently assessed the feasibility of functional electrical stimulation in roarers.
A horse in respiratory distress or displaying other signs of airway ailments warrants a call to a veterinarian
Vets examined upper airway obstruction in horses being ridden and when displaying “normal” head carriage.
Stay on top of the most recent Horse Health news with
